| Stage | VHI | % of rev | LIN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $628M | 100.00% | $9.4B | 100.00% | LIN ×14.98 |
| Gross profit | $142M | 22.56% | $4.4B | 47.24% | LIN +24.7pp |
| Operating income | $62M | 9.88% | $2.1B | 22.86% | LIN +13.0pp |
| Pre-tax income | $47M | 7.54% | $2.1B | 22.63% | LIN +15.1pp |
| Net income | $36M | 5.66% | $1.7B | 18.50% | LIN +12.8pp |
| Stage | VHI | LIN | Gap · A − B |
|---|---|---|---|
| Revenue | $628M100.00% | $9.4B100.00% | LIN ×14.98 |
| Gross profit | 22.56%$142M | 47.24%$4.4B | LIN +24.7pp |
| Operating income | 9.88%$62M | 22.86%$2.1B | LIN +13.0pp |
| Pre-tax income | 7.54%$47M | 22.63%$2.1B | LIN +15.1pp |
| Net income |
| 5.66%$36M |
| 18.50%$1.7B |
| LIN +12.8pp |
No shared counterparties.